SMALL CELL LUNG CANCER (SCLC)
Clinical trials for SMALL CELL LUNG CANCER (SCLC) explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CANCER (SCLC) trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CANCER (SCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to slow aggressive lung cancer
Disease control Not yet recruitingThis study tests a new treatment for people with extensive-stage small cell lung cancer who have not had treatment before. The approach combines the drug bemotuzumab with standard chemotherapy and anlotinib, followed by chest radiation. The goal is to see if this combination can …
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 17, 2026 00:58 UTC
-
New CAR t therapy targets Hard-to-Treat lung cancers in first human trial
Disease control Not yet recruitingThis early-phase study tests a new treatment called ML261 for people with advanced small cell lung cancer or certain neuroendocrine cancers that have stopped responding to standard therapies. ML261 uses a patient's own immune cells, modified to better recognize and attack cancer …
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE1 • Sponsor: Moonlight Bio, Inc • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New combo therapy aims to tame tough lung cancer
Disease control Not yet recruitingThis study tests how well people with small cell lung cancer tolerate a new drug, alisertib, when added to standard chemotherapy (paclitaxel). About 50 adults who have already tried at least one prior treatment will take alisertib pills twice daily for a week each cycle, plus IV …
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE2 • Sponsor: Puma Biotechnology, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Could a 50-year-old antipsychotic drug shrink hard-to-treat small cell cancers?
Disease control Not yet recruitingThis study tests penfluridol, a drug originally used for mental health, in 33 adults with advanced small cell lung or cervical cancer that has not responded to at least two prior treatments. The goal is to find a safe weekly dose and see if it can shrink tumors. Penfluridol is ta…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE1, PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Experimental combo targets rare lung cancer transformation
Disease control Not yet recruitingThis early-stage trial tests whether combining two drugs, lurbinectedin and osimertinib, is safe and works against a rare lung cancer called transformed small cell lung cancer. It is for adults whose cancer changed from a common type after prior treatment. The study will check fo…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE1, PHASE2 • Sponsor: Misty Shields • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC